| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/24/2008 | CN101328475A Nucleic acid molecule NRN1SR11 and use thereof in anti-cancer medicine preparation |
| 12/24/2008 | CN101328202A Bark of Melia toosendan extract and use thereof |
| 12/24/2008 | CN101328200A Antineoplastic compound, preparation and use thereof |
| 12/24/2008 | CN101328199A SiRNA inhibiting human cell cycle protein A2 expression and use thereof |
| 12/24/2008 | CN101328197A Production of glucosinolates from agricultural by-products and waste |
| 12/24/2008 | CN101328186A Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |
| 12/24/2008 | CN101328184A Dimeric cembrane tetraterpene compounds ruga soft coral sarcophyton lactone deoxyschizandrin and Schisandrin B, preparing methods and uses thereof |
| 12/24/2008 | CN101328175A Yageine derivates having antineoplastic activity |
| 12/24/2008 | CN101328172A 4-substituted 2,7-phthalazine compound, and preparation and usethereof |
| 12/24/2008 | CN101328166A 2-dihydroindole ketone derivate as protein kinase inhibitor and histone deacetylase inhibitor |
| 12/24/2008 | CN101328159A Taxone precursor anti-cancer drugs, medicinal composition and use thereof |
| 12/24/2008 | CN101328154A 3-alcoxymethyl amidine-1,2,4-benzotriazin derivates, preparation and use thereof |
| 12/24/2008 | CN101327328A Dendrimers targeting nano particle and preparation and application thereof |
| 12/24/2008 | CN101327317A Use of human erythrocyte membrane protein of foreign body in preparing medicament for treating cancer |
| 12/24/2008 | CN101327315A Use of maltose binding protein as immunopotentiator |
| 12/24/2008 | CN101327309A Chinese medicine for treating lymph cancer, nasopharyngeal carcinoma and brain cancer |
| 12/24/2008 | CN101327307A Medicament for treating cancer and preparation method |
| 12/24/2008 | CN101327258A Rehabilitation medicinal liquor for breast cancer patient |
| 12/24/2008 | CN101327241A Medicament for treating tumor |
| 12/24/2008 | CN101327237A Composition containing plant effective component and preparation method and use thereof |
| 12/24/2008 | CN101327226A Light-emitting microorganisms and cells for tumour diagnosis/therapy |
| 12/24/2008 | CN101327221A Medical use of Ophiopogon root saponin D as tissue factor pathway inhibitor |
| 12/24/2008 | CN101327214A Medicine use of isoquinoline alkaloids as tissue factor inhibitor |
| 12/24/2008 | CN101327206A Docetaxel injection and preparation method thereof |
| 12/24/2008 | CN101327205A Use of lipoxin in treating tumor |
| 12/24/2008 | CN101327201A Gossypol or liquid preparation of analogue thereof and preparation method and use thereof |
| 12/24/2008 | CN101327190A Anti-tumor long-circulating target liposomes for injections |
| 12/24/2008 | CN101327188A Bisphosphonates microemulsion and preparation method thereof |
| 12/24/2008 | CN101327186A Anticancer implantation agent |
| 12/24/2008 | CN101327185A Anticancer sustained-release implantation agent |
| 12/24/2008 | CN101327010A Method for preparing amber ginseng |
| 12/24/2008 | CN100445380C Therapeutically useful synthetic oligonucleotides |
| 12/24/2008 | CN100445293C Supermolecular carboplatinum derivatives, their preparation method, and pharmaceutical composition containing them as active ingredient and applications of the composition |
| 12/24/2008 | CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 12/24/2008 | CN100445270C Pyrimidine compounds |
| 12/24/2008 | CN100445252C Active compound bulbophyllum phenanthrene dimer B and its use |
| 12/24/2008 | CN100444895C Immunomodulator for treating malignant tumor |
| 12/24/2008 | CN100444842C Use of N-aryl heterocyclics |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/24/2008 | CN100444838C Use of inhibitors for treatment of disorders related to RTK hyperfunction |
| 12/24/2008 | CN100444837C Novel herbal chemical composition for treatment of cancer |
| 12/24/2008 | CA2855098A1 Antibodies to human programmed death receptor pd-1 |
| 12/24/2008 | CA2726419A1 Trans-chinnamic acid derivative and preparation method and the use thereof |
| 12/24/2008 | CA2692072A1 Methods and agents for inhibiting tumor growth |
| 12/24/2008 | CA2691522A1 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
| 12/24/2008 | CA2691417A1 Heterocyclic compounds and use thereof as erk inhibitors |
| 12/24/2008 | CA2691357A1 Antibodies to human programmed death receptor pd-1 |
| 12/24/2008 | CA2691322A1 Anti-cd20 therapeutic compositions and methods |
| 12/24/2008 | CA2691251A1 Preventive/remedy for cancer |
| 12/24/2008 | CA2691227A1 Activators and therapeutic applications thereof |
| 12/24/2008 | CA2691100A1 Protein kinase inhibitors and methods for using thereof |
| 12/24/2008 | CA2691091A1 Fusion protein, macromolecule assembled from the fusion protein, and its use in the prevention or treatment of human papillomavirus related diseases |
| 12/24/2008 | CA2691047A1 Platinum (iv) complexes |
| 12/24/2008 | CA2691033A1 Capsid proteins and uses therefore |
| 12/24/2008 | CA2690762A1 .alpha.-chloro and .alpha.-bromo phosphonate analogs of lysophosphatidic acid and methods of making and using thereof |
| 12/24/2008 | CA2690557A1 Imidazopyrazines as protein kinase inhibitors |
| 12/24/2008 | CA2690449A1 Synergistic treatment of cells that express epha2 and erbb2 |
| 12/24/2008 | CA2690141A1 Inhibitors of janus kinases |
| 12/24/2008 | CA2689521A1 Anti-igf antibodies |
| 12/24/2008 | CA2689393A1 Alkynylpyrimidines as tie2 kinase inhibitors |
| 12/24/2008 | CA2687909A1 Indolin-2-ones and aza-indolin-2-ones |
| 12/24/2008 | CA2687255A1 Heteroarylamide pyrimidone derivatives |
| 12/23/2008 | US7468380 Nitrogen-containing aromatic derivatives |
| 12/23/2008 | US7468372 7-aminosulfonylamino-, aminocarbonylamino- and oxycarbonylamino-substituted pyrrazolo[1,5-a]pyrimidine derivatives, useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis |
| 12/23/2008 | US7468368 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 12/23/2008 | US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression; |
| 12/23/2008 | US7468366 Cytotoxic agents |
| 12/23/2008 | US7468361 For therapy of skin conditions selected from the group consisting of dermatitis, eczema, keratosis, lack of skin firmness, wrinkles, lack of dermal hydration and insufficient sebum secretion |
| 12/23/2008 | US7468359 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 12/23/2008 | US7468356 Modulation of insulin like growth factor I receptor expression |
| 12/23/2008 | US7468270 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 12/23/2008 | US7468181 Means and methods for the production of adenovirus vectors |
| 12/23/2008 | CA2422359C Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
| 12/23/2008 | CA2419067C Injectable composition comprising benzimidazole compound and strong alkali |
| 12/23/2008 | CA2249320C Glycosylated humanized b-cell specific antibodies |
| 12/23/2008 | CA2245267C Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 12/23/2008 | CA2212750C Humanized antibodies against cd3 |
| 12/23/2008 | CA2182889C Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor |
| 12/18/2008 | WO2008154439A1 Methods and compositions for inducing apoptosis in cancer cells |
| 12/18/2008 | WO2008154262A1 Stabilized amorphous forms of imatinib mesylate |
| 12/18/2008 | WO2008154259A1 Biphenylcarboxamide derivatives as hedgehog pathway modulators |
| 12/18/2008 | WO2008154004A2 Inhibition of tumor metastases using protein kinase c (pkc) inhibitors |
| 12/18/2008 | WO2008153947A2 Heterocyclic compounds as raf kinase modulators |
| 12/18/2008 | WO2008153858A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer |
| 12/18/2008 | WO2008153730A2 Method for treating proliferative disorders associated with mutations in c-met |
| 12/18/2008 | WO2008153705A2 Methods of treating, diagnosing and detecting fgf21-associated disorders |
| 12/18/2008 | WO2008153443A1 Method for bio-controllable photo-dynamic therapy |
| 12/18/2008 | WO2008153207A1 Bicycloaniline derivative |
| 12/18/2008 | WO2008153158A1 Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food |
| 12/18/2008 | WO2008153150A1 Method for culturing cell population containing nk cells and use of the cell population |
| 12/18/2008 | WO2008153091A1 Screening method |
| 12/18/2008 | WO2008153072A1 Gene sensitive to bone/joint disease and use thereof |
| 12/18/2008 | WO2008153042A1 Anti-tumor agent |
| 12/18/2008 | WO2008153027A1 Pyrroloquinoline derivative and use thereof |
| 12/18/2008 | WO2008152822A1 Medicinal agent |
| 12/18/2008 | WO2008152764A1 Pharmaceutical composition |
| 12/18/2008 | WO2008152758A1 Therapeutic agent for malignant tumor derived from alpinia officinarum rhizome |
| 12/18/2008 | WO2008152609A1 Interferon alpha sequential regimen for treating cancers |
| 12/18/2008 | WO2008152394A1 Pharmaceutical compounds |
| 12/18/2008 | WO2008152392A2 Use of beta-gbp (galactoside binding protein) |